Lentinan prolonged survival in patients with gastric cancer receiving S-1-based chemotherapy.

@article{Ina2011LentinanPS,
  title={Lentinan prolonged survival in patients with gastric cancer receiving S-1-based chemotherapy.},
  author={Kenji Ina and Ryuichi Furuta and Takae Kataoka and Satoshi Kayukawa and Takashi Yoshida and Takaya Miwa and Yoshitaka Yamamura and Yuuki Takeuchi},
  journal={World journal of clinical oncology},
  year={2011},
  volume={2 10},
  pages={339-43}
}
AIM To examine whether administration of lentinan, purified β-1, 3-glucan, can prolong survival in advanced gastric cancer patients receiving S-1-based chemotherapy. METHODS Since 2004, 78 patients with metastatic or recurrent gastric cancer have received S-1-based chemotherapy as first-line treatment. Survival, side effects, and the ratio of granulocytes/lymphocytes (G/L ratio) were compared between 2 groups of patients who received chemo-immunotherapy using lentinan and chemotherapy alone… CONTINUE READING

From This Paper

Topics from this paper.
13 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 13 extracted citations

Similar Papers

Loading similar papers…